Research Topics
| B MovsasSummaryAffiliation: Fox Chase Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancerB Movsas
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
Oncology (Williston Park) 15:1549-58. 2001..Future strategies include novel chemotherapy, methods to reduce toxicity, the emerging role of neoadjuvant therapy, and the promise of new biologic agents...
Quantifying radiation therapy-induced brain injury with whole-brain proton MR spectroscopy: initial observationsB Movsas
Department of Radiation Oncology, Fox Chase Cancer Center, 7701 Burholme Ave, Philadelphia, PA 19111, USA
Radiology 221:327-31. 2001..To quantify the extent of neuronal cell loss imparted to the brain by means of radiation therapy through the decline of the amino acid derivative N-acetylaspartate (NAA) by using proton (hydrogen 1) magnetic resonance (MR) spectroscopy...
Quality-of-life trials in lung cancer: past achievements and future challengesBenjamin Movsas
Department of Radiation Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
Hematol Oncol Clin North Am 18:161-86. 2004..Future studies should focus on incorporating QOL into phase III studies with clear hypotheses that can ultimately lead to clinically meaningful interventions...
Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancerBenjamin Movsas
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
Oncology (Williston Park) 16:90-5, 100; discussion 100-2, 105-6. 2002..Future strategies include novel chemotherapy, methods to reduce toxicity, the emerging role of neoadjuvant therapy, and the promise of new biologic agents...
Radiotherapy patterns of care study in lung carcinomaB Movsas
Fox Chase Cancer Center, 7701 Burholme Ave, Philadelphia, PA 19111, USA
J Clin Oncol 21:4553-9. 2003..For the first time, a lung Patterns of Care Study was conducted to determine the national patterns of radiation (RT) practice in patients treated for nonmetastatic lung cancer in 1998 to 1999...
Quality of life in oncology trials: a clinical guideBenjamin Movsas
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Semin Radiat Oncol 13:235-47. 2003..The future challenge will be to translate QOL results into clinically meaningful interventions...
Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancerB Movsas
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Int J Radiat Oncol Biol Phys 42:43-50. 1998....
The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studiesB Movsas
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Int J Radiat Oncol Biol Phys 45:1143-9. 1999..The purpose of this study is to analyze the impact of age, histology, Karnofsky performance status (KPS), and specific toxicities on the median survival time (MST) and quality-adjusted survival (QTime) for each treatment strategy...
Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) studyB Movsas
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
Cancer 89:2018-24. 2000..The purpose of this study was to analyze the extent of hypoxia in prostate carcinoma tumors using the Eppendorf pO(2) microelectrode and correlate this with pretreatment characteristics and prognostic factors...
Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRTL Wang
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
J Appl Clin Med Phys 5:29-41. 2004..78). In conclusion, the use of the mMLC for IMRT of the prostate resulted in significant improvement in the DVH parameters of the prostate and critical organs, which may improve the therapeutic ratio...
Surgical patterns of care in operable lung carcinoma treated with radiationJoe Y Chang
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Thorac Oncol 1:526-31. 2006..To determine the national surgical practice patterns of care for operable lung cancer patients treated with radiation...
Computed tomography-magnetic resonance image fusion: a clinical evaluation of an innovative approach for improved tumor localization in primary central nervous system lesionsJ P Lattanzi
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
Radiat Oncol Investig 5:195-205. 1997..The importation of MRI data into three-dimensional treatment planning is therefore crucial to accurate tumor localization. The fusion process simplifies and improves precision of this task...
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01Benjamin Movsas
Department of Radiation Oncology, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI 48202, USA
J Clin Oncol 23:2145-54. 2005..To test the ability of the cytoprotectant, amifostine, to reduce chemoradiotherapy-induced esophagitis and evaluate its influence on quality of life (QOL) and swallowing symptoms...
The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancerRojymon Jacob
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111-2497, USA
Cancer 100:538-43. 2004..CONCLUSIONS: Escalation of RT dose reduced the rates of BF, DM, and OM significantly in patients with prostate cancer. The inclusion of YOT had a pronounced effect on these correlations that may confound interpretation...
A method for repositioning of stereotactic brain patients with the aid of real-time CT image guidanceK Paskalev
Department of Radiation Oncology Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Phys Med Biol 50:N201-7. 2005..05 mm, and they were not statistically significant. The random errors (one standard deviation) were from 0.35 mm (lateral) to 0.58 mm (vertical). The average value of the combined 3D difference was 0.75 mm...
Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancerBenjamin Movsas
Department of Radiation Oncology, Henry Ford Health Systems, 2799 W Grand Blvd, Detroit, MI 48202, USA
J Thorac Oncol 5:673-9. 2010..Our study assessed consolidation with either gemcitabine alone or with docetaxel after identical chemoradiation as used in Southwest Oncology Group 9504...
Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvementRojymon Jacob
Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
Int J Radiat Oncol Biol Phys 61:695-701. 2005..These data suggest that the primary tumor takes precedence over lymph node coverage or the use of STAD. Doses >70 Gy are of paramount importance in such intermediate- and high-risk patients...
To move or not to move: measurements of prostate motion by urethrography using MRID Mah
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Int J Radiat Oncol Biol Phys 50:947-51. 2001..Sagittal MRI scans were acquired immediately before and after a localization urethrogram to determine the extent of displacement...
Outcomes research in cancer clinical trial cooperative groups: the RTOG modelD W Bruner
Radiation Therapy Oncology Group, Philadelphia, PA, USA
Qual Life Res 13:1025-41. 2004....
Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12Ritsuko Komaki
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 62:342-50. 2005..The purpose of RTOG 97-12 was to determine the maximum tolerated dose (MTD) of thoracic radiation therapy (RT) with concurrent chemotherapy for patients with limited-stage small-cell lung cancer...
Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysisBenjamin Movsas
Department of Radiation Oncology, Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202, USA
Int J Radiat Oncol Biol Phys 68:1145-50. 2007..To identify factors significantly influencing accrual to clinical protocols by analyzing radiation Patterns of Care Study (PCS) surveys of 3,047 randomly selected radiotherapy (RT) patients...
ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065 6007, USA
J Am Coll Radiol 6:85-95. 2009..Biologic therapies such as erlotinib and bevacizumab have been incorporated into every phase of chemotherapy with good results...
Exploring the role of the radioprotector amifostine in locally advanced non-small cell lung cancer: Radiation Therapy Oncology Group trial 98-01Benjamin Movsas
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Semin Radiat Oncol 12:40-5. 2002....
Intracranial fibrosarcoma arising 5 years after chemotherapy alone for glioblastoma multiforme in a childJ M Kaminski
Department of Radiation Oncology, Fox Chase Cancer Center, Albert Einstein Medical Center, Philadelphia, PA, USA
Pediatr Neurosurg 33:257-260. 2000..She remains alive and recurrence-free 7 years following the diagnosis of her second intracranial malignancy...
Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancerD Cvetkovic
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
Urology 57:821-5. 2001..The results of our study further support the exploration of antiangiogenesis strategies for the treatment of human prostate cancer...
Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findingsBenjamin Movsas
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
Urology 60:634-9. 2002..The P/M PO2 ratio was the strongest predictor for biochemical control on stepwise multivariate analysis. Longer follow up with more patients is planned to confirm this result...
Amifostine in chemoradiation therapy for non-small cell lung cancer: review of experience and design of a phase II trial assessing subcutaneous and intravenous bolus administrationMaria Werner-Wasik
Department of Radiation Oncology, Kimmel Cancer Center, Jefferson Medical College, Thomas Jefferson University Hospital, 111 South 11th Street, Bodine Center, Philadelphia, PA 19107, USA
Semin Oncol 32:S105-8. 2005..These issues are to be addressed in a randomized phase II trial of amifostine given subcutaneously or via intravenous bolus in non-small cell lung cancer patients undergoing chemoradiation treatment...
A technique of using gated-CT images to determine internal target volume (ITV) for fractionated stereotactic lung radiotherapyJian Yue Jin
Department of Radiation Oncology, Henry Ford Hospital, Detroit, MI, USA
Radiother Oncol 78:177-84. 2006..To develop and evaluate a technique and procedure of using gated-CT images in combination with PET image to determine the internal target volume (ITV), which could reduce the planning target volume (PTV) with adequate target coverage...
Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck regionFarzan Siddiqui
Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, USA
Int J Radiat Oncol Biol Phys 74:1047-53. 2009..To determine the feasibility, safety, and efficacy of stereotactic body radiation therapy (SBRT), also known as radiosurgery, in patients with head-and-neck cancers...
Quantification of incidental dose to potential clinical target volume (CTV) under different stereotactic body radiation therapy (SBRT) techniques for non-small cell lung cancer - tumor motion and using internal target volume (ITV) could improve dose distrJian Yue Jin
Department of Radiation Oncology, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI 48202, USA
Radiother Oncol 85:267-76. 2007..This study aimed to quantify the incidental dose to the potential CTV under different SBRT techniques...
Randomized phase II study of amifostine mucosal protection by either subcutaneous injection or rapid IV bolus for patients with inoperable stage II-IIIA/B or stage IV non-small cell lung cancer with oligometastases receiving concurrent radiochemotherapy wMaria Werner-Wasik
Kimmel Cancer Center of Jefferson Medical College, Philadelphia, PA 19107, USA
Semin Oncol 31:47-51. 2004....
A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (ART) in locally advanced non-small cell lung cancer (NSCLC)Samir H Patel
Department of Radiation Oncology, Henry Ford Hospital, Detroit, Michigan 48202, USA
J Thorac Oncol 2:831-7. 2007..We investigated the toxicity, response rate, and overall survival (OS) with induction carboplatin and vinorelbine followed by concomitant topotecan and ART in patients with locally advanced/unresectable NSCLC...
Gender differences in pretreatment quality of life in a prospective lung cancer trialFarzan Siddiqui
Department of Radiation Oncology, Henry Ford Health System, Detroit, Michigan 48202, USA
J Support Oncol 6:33-9. 2008..Understanding the interaction between gender and performance status could lead to better prognosticators and potentially could tailor interventions for specific groups of patients with lung cancer...
Patterns of missing mini mental status exam (MMSE) in radiation therapy oncology group (RTOG) brain cancer trialsK Bae
Statistics Department, Radiation Therapy Oncology Group, 1818 Market St Suite 1600, Philadelphia, PA 19103, USA
J Neurooncol 105:383-95. 2011....
Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06C B Scott
Radiation Therapy Oncology Group, Statistical Unit, Philadelphia, PA 19107 2914, USA
Int J Radiat Oncol Biol Phys 40:51-5. 1998..The purpose of the current analysis was to validate the RPA classes with a new dataset (RTOG 90-06), determine the predictive power of the RPA classes, and establish the usefulness of the database norms for the RPA classes...
Impact of fraction size on lung radiation toxicity: hypofractionation may be beneficial in dose escalation of radiotherapy for lung cancersJin Yue Jin
Department of Radiation Oncology, Henry Ford Hospital, Detroit, MI 48202, USA
Int J Radiat Oncol Biol Phys 76:782-8. 2010..To assess how fraction size impacts lung radiation toxicity and therapeutic ratio in treatment of lung cancers...
Treatment of stage II non-small cell lung cancerWalter J Scott
Department of Surgical Oncology, Section of Thoracic Surgical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
Chest 123:188S-201S. 2003..Superior sulcus tumors are discussed elsewhere in these guidelines...
Emotional well-being does not predict survival in head and neck cancer patients: a Radiation Therapy Oncology Group studyJames C Coyne
Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
Cancer 110:2568-75. 2007..The objective of the current study was to examine whether emotional well-being predicted survival in a large sample of patients with head and neck cancer who were participating in multicenter clinical trials...
Developing a radiation error scoring system to monitor quality control events in a radiation oncology departmentAndre Konski
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
J Am Coll Radiol 6:45-50. 2009..The aims of this study were to evaluate the factors contributing to errors in the treatment of cancer patients undergoing radiation therapy and to develop a grading system that allows for the comparison of errors...
Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition)Walter J Scott
Fox Chase Cancer Center Suite C 312, 333 Cottman Ave, Philadelphia, PA 19111, USA
Chest 132:234S-242S. 2007..Adjuvant therapy (both chemotherapy and radiation therapy) and the use of larger fractions of radiotherapy delivered to a smaller area for nonoperative treatment of early stage NSCLC have shown promising results...
I'm so tired: biological and genetic mechanisms of cancer-related fatigueAndrea Barsevick
Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA, USA
Qual Life Res 19:1419-27. 2010....
A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patientsRobert A Schnoll
Fox Chase Cancer Center, Philadelphia, Cheltenham, Pennsylvania 19012, USA
Ann Behav Med 30:1-11. 2005....
A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancerSteven J Feigenberg
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
J Thorac Oncol 2:287-92. 2007..To determine the feasibility of combining concurrent carboplatin/paclitaxel and thoracic radiotherapy (TRT) for completely resected stage II and IIIA non-small cell lung cancer...
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trialAlan Pollack
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Int J Radiat Oncol Biol Phys 64:518-26. 2006..The dosimetry and acute toxicity are described in the first 100 men enrolled in a randomized trial...
Disadvantage of men living alone participating in Radiation Therapy Oncology Group head and neck trialsAndre A Konski
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
J Clin Oncol 24:4177-83. 2006..This study evaluated whether males without partners were disadvantaged for survival in Radiation Therapy Oncology Group (RTOG) head and neck cancer clinical trials...
Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinomaCorey J Langer
Fox Chase Cancer Center, Philadelphia, PA 19111, USA
J Thorac Oncol 2:203-9. 2007..6 months in advanced NSCLC (Jagasia et al.; Clinical Cancer Research 7: 68, 2001). A weekly schedule for each agent (versus less frequent doses) limits toxicity and increases the opportunity for radiosensitization...
The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trialsFarzan Siddiqui
Department of Radiation Oncology, Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202, USA
J Thorac Oncol 5:631-9. 2010..A meta-analysis was conducted to determine the influence of gender, race, and marital status on overall survival (OS) in Radiation Therapy Oncology Group nonoperative non-small cell lung cancer trials...
Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratioAlan E Nahum
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Int J Radiat Oncol Biol Phys 57:391-401. 2003..It is strongly suggested that severe hypoxia in the prostates of certain patients limits the overall cancer cure rate by conventional radiation therapy...
A method for increased dose conformity and segment reduction for SMLC delivered IMRT treatment of the prostateRobert A Price
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Int J Radiat Oncol Biol Phys 57:843-52. 2003..The focus of this work is to develop a practical planning method that results in increased dose conformity and reduced treatment time for segmental multileaf collimation (sMLC) based intensity-modulated radiation therapy (IMRT) delivery...
MRI simulation: effect of gradient distortions on three-dimensional prostate cancer plansDennis Mah
Department of Radiation Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
Int J Radiat Oncol Biol Phys 53:757-65. 2002..To quantify the dosimetric consequences of external patient contour distortions produced on low-field and high-field MRIs for external beam radiation of prostate cancer...
Longitudinal predictors of continued tobacco use among patients diagnosed with cancerRobert A Schnoll
Fox Chase Cancer Center, Psychological and Behavioral Medicine Program, Cheltenham, PA 19012, USA
Ann Behav Med 25:214-22. 2003..continuous smokers exhibited a significantly lower level of risk perceptions than continuous abstainers. These findings can be useful for the development and evaluation of treatments to promote smoking cessation among cancer patients...
Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollmentRobert A Schnoll
Division of Population Science, Fox Chase Cancer Center, 510 Township Line Road, Cheltenham, Pennsylvania 19012, USA
Head Neck 26:278-86. 2004..We examined reasons patients provide for declining smoking treatment and compared treatment decliners to enrollees...
Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patientsRobert A Schnoll
Division of Population Science, Fox Chase Cancer Center, 510 Township Line Road, Cheltenham, PA 19012, USA
Psychooncology 13:346-58. 2004..These findings can help guide the development of smoking cessation interventions for cancer patients...
Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapyAlan Pollack
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Int J Radiat Oncol Biol Phys 57:19-23. 2003..However, little evidence is available to show that BF is associated with death for patents with prostate cancer treated with radiotherapy. We examined the relationship between BF and death from prostate cancer...
Correlates of tobacco use among smokers and recent quitters diagnosed with cancerRobert A Schnoll
Psychosocial and Behavioral Medicine Program, Fox Chase Cancer Center, 510 Township Line Road, Cheltenham, PA 19012, USA
Patient Educ Couns 46:137-45. 2002....
Stereotactic IMRT for prostate cancer: setup accuracy of a new stereotactic body localization systemLu Wang
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
J Appl Clin Med Phys 5:18-28. 2004..A rigid frame system serves as a reliable alignment reference in terms of repositioning patients into the planning position, while skin-based reference showed larger deviations in repositioning patients...
Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?Corey J Langer
Fox Chase Cancer Center, 333 Cotman AVE, Philadelphia, PA 19111, USA
Lung Cancer 48:93-102. 2005..ASCO 2000;19:484a; Furuse. JCO 1999;17:2692-9; Zatloukal. ASCO 2002;A-1159]. Data are less secure regarding the role of chemotherapy in stage I and II NSCLC...
The surgical management of superior sulcus tumors: a retrospective review with long-term follow-upMelvyn Goldberg
Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 2497, USA
Ann Thorac Surg 79:1174-9. 2005..We reviewed our experience with multimodality therapy for superior sulcus tumors to identify aspects of treatment that impact survival...
Mindless or mindful? Radiation oncologists' perspectives on the evolution of prostate cancer treatmentAlan Pollack
Department of Radiation Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
Urol Clin North Am 30:337-49, x. 2003..In summary, advances in radiation oncology have led to significant gains in prostate cancer control. Clinical prognostic factor-based patient selection is central to the optimization of outcome...
Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04K J Murray
Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
Int J Radiat Oncol Biol Phys 48:59-64. 2000..This study examines the importance of the MMSE in predicting outcome in a group of patients treated with an accelerated fractionation regimen of 30 Gy in 10 daily fractions in 2 weeks...
Optimum beam angles for the conformal treatment of lung cancer: a CT simulation studyI J Das
Department of Radiation Oncology, University of Pennsylvania, 3400 Spruce St, 2 Donner Building, Philadelphia, PA 19104, USA
Int J Cancer 90:359-65. 2000..A CT simulator is ideally suited for simulation of lung cancer to maximize the clearance from the spinal cord and minimize the additional lung volume irradiated. Int. J. Cancer (Radiat. Oncol. Invest.) 90, 359-365 (2000)...
Can costs be measured and predicted by modeling within a cooperative clinical trials group? Economic methodologic pilot studies of the radiation therapy oncology group (RTOG) studies 90-03 and 91-04J B Owen
Radiation Therapy Oncology Group, American College of Radiology, 1101 Market Street, Suite 1400, Philadelphia, PA 19107, USA
Int J Radiat Oncol Biol Phys 49:633-9. 2001....
Hypoxia in human prostate carcinoma: an Eppendorf PO2 studyB Movsas
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
Am J Clin Oncol 24:458-61. 2001..More patients will be accrued to this study to ultimately correlate the oxygenation status in prostate carcinoma tumors with treatment outcome...
2D/3D image fusion for accurate target localization and evaluation of a mask based stereotactic system in fractionated stereotactic radiotherapy of cranial lesionsJian Yue Jin
Department of Radiation Oncology, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, Michigan 48202, USA
Med Phys 33:4557-66. 2006..The overall uncertainty of the mask system was +/-4 mm, and the reproducibility was +/-2.9 mm in terms of 95% CI. The study demonstrated that the image guidance system provides accurate and precise target positioning...
Radiation pulmonary toxicity: from mechanisms to managementPaul R Graves
Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA, USA
Semin Radiat Oncol 20:201-7. 2010....
Effects of prescription depth, cylinder size, treatment length, tip space, and curved end on doses in high-dose-rate vaginal brachytherapyShidong Li
Department of Radiation Oncology, Henry Ford Health System, Detroit, Michigan 48202, USA
Int J Radiat Oncol Biol Phys 67:1268-77. 2007..To determine the effects of the prescription depth, cylinder size, treatment length, tip space, and curved end on high-dose-rate vaginal brachytherapy (HDR-VBT) of endometrial cancer...
Metastatic meningioma to the lung with multiple pleural metastasesJ M Kaminski
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
Am J Clin Oncol 24:579-82. 2001..We report an interesting case of a malignant meningioma that invaded through the skull in the frontal sinus that later metastasized to the left lung with multiple pulmonary and pleural nodules...
Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiformeC J Langer
Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Int J Radiat Oncol Biol Phys 51:113-9. 2001..The Radiation Therapy Oncology Group (RTOG) therefore mounted a Phase II study to determine the feasibility and efficacy of conventional EBRT and concurrent weekly TAX at its MTD...
Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostineLoren K Mell
University of California San Diego, Department of Radiation Oncology, La Jolla, California, USA
Expert Opin Drug Metab Toxicol 4:1341-50. 2008..Amifostine is a cytoprotector that can reduce toxicity and potentially improve the therapeutic ratio of radiotherapy...
Analysis of outcomes in radiation oncology: an integrated computational platformDezhi Liu
Department of Radiation Oncology, Henry Ford Health System, 2799 West Grand Boulevard, Detroit, Michigan 48202, USA
Med Phys 36:1680-9. 2009..In addition the database is web-based and accessible by multiple users, facilitating its convenient application and use...
Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 97-14William F Hartsell
Department of Radiation Oncology, Advocate Good Samaritan Cancer Center, Downers Grove, Illinois 60515, USA
J Palliat Med 11:723-8. 2008..To determine if physician prediction of survival duration (PSD) is accurate for patients with metastatic breast or prostate cancer...
Clinical, dosimetric, and radiographic correlation of radiation injury involving the brainstem and the medial temporal lobes following stereotactic radiotherapy for neoplasms of central skull baseStefano Schipani
Department of Radiation Oncology, Henry Ford Health System, 2799 West Grand Blvd, Detroit, MI, 48202, USA
J Neurooncol 98:177-84. 2010..Brainstem lesions occurred earlier than temporal lobe RI. The majority of the RI lesions, not mixed with the tumor in this study, showed radiographic and clinical improvement with steroid and symptomatic treatments...
Recent advances and dilemmas in the radiotherapeutic management of locally advanced non-small cell lung cancerBenjamin Movsas
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
Methods Mol Med 75:489-505. 2003
Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801Benjamin Movsas
Department of Radiation Oncology, Henry Ford Hospital, Detroit, MI 48202, USA
J Clin Oncol 27:5816-22. 2009..To determine the added value of quality of life (QOL) as a prognostic factor for overall survival (OS) in patients with locally advanced non-small-cell lung cancer (NSCLC) treated on Radiation Therapy Oncology Group RTOG-9801...
Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysisFarzan Siddiqui
Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, USA
Int J Radiat Oncol Biol Phys 70:353-60. 2008....
The role of radiation therapy and chemotherapy in the management of airway tumors other than small-cell carcinoma and non-small-cell carcinomaJoseph M Kaminski
Department of Radiation Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
Chest Surg Clin N Am 13:149-67. 2003..In the future, patients might receive individually tailored therapy based upon unique molecular-genetic alterations of the tumor...
Quality-of-life outcomes in oncologyFarzan Siddiqui
Department of Radiation Oncology, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, and Department of Radiation Oncology, Boston University Medical Center, MA, USA
Hematol Oncol Clin North Am 20:165-85. 2006..The current challenge is to understand better the clinical relevance of QOL research in oncology. QOL studies should focus on phase III trials with clear hypotheses that can lead to clinically meaningful interventions...
Radiation esophagitis: Predictive factors and preventive strategiesJeffrey Bradley
Department of Radiation Oncology, Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, MO 63110, USA
Semin Radiat Oncol 14:280-6. 2004..Preventive strategies to minimize this toxicity also are explored. Overall, this article reviews the current understanding of radiation toxicity for the esophagus...
Prostate cancer gene therapy clinical trialsSvend O Freytag
Department of Radiation Oncology, Henry Ford Health System, Detroit, Michigan 48202, USA
Mol Ther 15:1042-52. 2007..Much work lies ahead. Nevertheless, for the time being, these studies provide hope that gene therapy may someday earn a place in the management of prostate cancer...
Comparison of similarity measures for rigid-body CT/Dual X-ray image registrationsJinkoo Kim
Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, USA
Technol Cancer Res Treat 6:337-46. 2007..In the clinical applications, registrations starting with the mutual information followed by the gradient difference may provide the best accuracy and the most robustness...
Daily target localization for prostate patients based on 3D image correlationK Paskalev
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Phys Med Biol 49:931-9. 2004..The impact of image noise on the performance of the algorithm has been tested. The results show that the algorithm accurately adjusts for target positional changes even with Gaussian noise levels as high as 20% inserted...
How often are previously undetected radiographic abnormalities detected at the time of CT simulation for breast cancer patients?Sishir Rao
Department of Radiation Oncology, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202, USA
Am J Clin Oncol 33:262-4. 2010..The purpose of this analysis was to determine the percentage of cases in which a previously undetected radiographic finding was found on review of CT simulation images by diagnostic radiology...
Processes of change related to smoking behavior among cancer patientsRobert A Schnoll
Division of Population Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
Cancer Pract 10:11-9. 2002..These strategies are discussed within the context of models and guidelines for smoking cessation in clinical practice...
Imaging response in malignant glioma, RTOG 90-06Robert A Lustig
Hospital of the University of Pennsylvania, Department of Radiation Oncology, Philadelphia, PA 19104, USA
Am J Clin Oncol 30:32-7. 2007..This study compared patients treated with hyperfractionated radiation and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) to standard fractionation and BCNU...
Dose delivered from Varian's CBCT to patients receiving IMRT for prostate cancerNing Wen
Henry Ford Health System, Detroit, MI, USA
Phys Med Biol 52:2267-76. 2007..The surface and in vivo doses were also measured for phantoms at the central-axis setup. The difference was less than approximately 12% to the table-drop setup...
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II studyDavid S Ettinger
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231 1000, USA
J Clin Oncol 23:4991-8. 2005....
Will future progress in non-small-cell lung cancer be step by step... or by leaps and bounds?Benjamin Movsas
J Clin Oncol 23:5859-61. 2005
Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group (RTOG) analysisBenjamin Movsas
Radiation Oncology, Henry Ford Health System, Detroit, MI, USA
Int J Radiat Oncol Biol Phys 65:830-5. 2006..The purpose of this analysis was to assess the impact of pretreatment factors on quality of life (QOL) in cancer patients...
A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04)Jeffrey D Bradley
Radiation Oncology Center, Washington University Medical Center, St Louis, MO 63110, USA
Int J Radiat Oncol Biol Phys 52:1173-9. 2002..Based on these data, the Radiation Therapy Oncology Group (RTOG) initiated a Phase III trial to test the efficacy of beta-interferon in poor-risk patients with Stages IIIA and IIIB non-small-cell lung carcinoma...
Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancerBenjamin Movsas
Henry Ford Health System, Radiation Oncology, Detroit, MI 48202, USA
Am J Clin Oncol 29:435-41. 2006..The purpose of this phase II study was to prospectively determine the efficacy of preoperative chemoradiation with a hyperfractionated (Hfx) RT boost to 61.8 Gy in locally advanced rectal cancer...
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31Miljenko V Pilepich
University of California, Los Angeles, School of Medicine, Los Angeles, CA, USA
Int J Radiat Oncol Biol Phys 61:1285-90. 2005..Radiation Therapy Oncology Group protocol 85-31 was designed to evaluate the effectiveness of adjuvant androgen suppression, using goserelin, in unfavorable prognosis carcinoma of the prostate treated with definitive radiotherapy (RT)...
Examining margin reduction and its impact on dose distribution for prostate cancer patients undergoing daily cone-beam computed tomographyRabih Hammoud
Josephine Ford Downriver Center for Oncology, Henry Ford Health System, Brownstown, MI, USA
Int J Radiat Oncol Biol Phys 71:265-73. 2008..To examine the dosimetric impact of margin reduction and quantify residual error after three-dimensional (3D) image registration using daily cone-beam computed tomography (CBCT) for prostate cancer patients...
Imaging to optimally stage lung cancer: conventional modalities and PET/CTMylene T Truong
Department of Diagnostic Radiology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Am Coll Radiol 1:957-64. 2004..This article reviews current recommendations regarding the staging of patients with NSCLC and addresses the role of PET/CT...
Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118Benjamin W Corn
Department of Radiation Oncology, Tel Aviv Medical Center, Tel Aviv, Israel
Int J Radiat Oncol Biol Phys 71:71-8. 2008..This secondary analysis of 156 patients examined neurocognitive and quality of life (QOL) outcomes...
Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: a meta-analysisLoren K Mell
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA
Int J Radiat Oncol Biol Phys 68:111-8. 2007..Studies with sufficient statistical power to address this question are lacking...
A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118)Jonathan P S Knisely
Department of Therapeutic Radiology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT 06520 8040, USA
Int J Radiat Oncol Biol Phys 71:79-86. 2008..To compare whole-brain radiation therapy (WBRT) with WBRT combined with thalidomide for patients with brain metastases not amenable to resection or radiosurgery...
Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networksDeborah Watkins Bruner
Radiation Therapy Oncology Group, University of Pennsylvania, School of Nursing American College of Radiology Imaging Network, Philadelphia, PA 19104 6096, USA upenn edu
J Clin Oncol 25:5051-7. 2007..The objective of this report is to provide a historical overview of and the issues and challenges inherent in the incorporation of patient-reported outcomes (PROs) into multinational cancer clinical trials in the cancer cooperative groups...
